Published in Mil Med on February 01, 2002
Links between innate immunity and normal tissue radiobiology. Radiat Res (2010) 1.19
Cellular Senescence - its role in cancer and the response to ionizing radiation. Genome Integr (2011) 0.98
Epidermal growth factor receptor vIII expression in U87 glioblastoma cells alters their proteasome composition, function, and response to irradiation. Mol Cancer Res (2008) 0.87
Breast cancer adaptive resistance: HER2 and cancer stem cell repopulation in a heterogeneous tumor society. J Cancer Res Clin Oncol (2013) 0.87
Response of cyclin B1 to ionizing radiation: regulation by NF-kappaB and mitochondrial antioxidant enzyme MnSOD. Anticancer Res (2004) 0.85
Molecular basis of 'hypoxic' breast cancer cell radio-sensitization: phytochemicals converge on radiation induced Rel signaling. Radiat Oncol (2013) 0.85
Cell cycle regulators guide mitochondrial activity in radiation-induced adaptive response. Antioxid Redox Signal (2014) 0.81
Typical cell signaling response to ionizing radiation: DNA damage and extranuclear damage. Chin J Cancer Res (2012) 0.80
Imaging of radiation effects on cellular 26S proteasome function in situ. Int J Radiat Biol (2009) 0.79
Inference of causal networks from time-varying transcriptome data via sparse coding. PLoS One (2012) 0.78
Colorectal Carcinogenesis, Radiation Quality, and the Ubiquitin-Proteasome Pathway. J Cancer (2016) 0.77
Consequences of low dose ionizing radiation exposure on the hippocampal microenvironment. PLoS One (2015) 0.77
The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst (2006) 10.06
Do erythropoietin receptors on cancer cells explain unexpected clinical findings? J Clin Oncol (2006) 5.56
Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2. Cancer Cell (2004) 2.71
In vivo imaging, tracking, and targeting of cancer stem cells. J Natl Cancer Inst (2009) 2.39
Metabolic state of glioma stem cells and nontumorigenic cells. Proc Natl Acad Sci U S A (2011) 2.13
Local resistance switching at grain and grain boundary surfaces of polycrystalline tungsten oxide films. Nanotechnology (2011) 2.09
A sense of danger from radiation. Radiat Res (2004) 2.02
Radiation-induced reprogramming of breast cancer cells. Stem Cells (2012) 1.83
Survival and self-renewing capacity of breast cancer initiating cells during fractionated radiation treatment. Breast Cancer Res (2010) 1.59
Safety and efficacy of hyperbaric oxygen therapy for the treatment of interstitial cystitis: a randomized, sham controlled, double-blind trial. J Urol (2006) 1.47
National Institutes of Health funding in radiation oncology: a snapshot. Int J Radiat Oncol Biol Phys (2013) 1.42
Effects of recombinant erythropoietin on breast cancer-initiating cells. Neoplasia (2007) 1.29
Context-dependent role of angiopoietin-1 inhibition in the suppression of angiogenesis and tumor growth: implications for AMG 386, an angiopoietin-1/2-neutralizing peptibody. Mol Cancer Ther (2010) 1.27
Irradiation of the potential cancer stem cell niches in the adult brain improves progression-free survival of patients with malignant glioma. BMC Cancer (2010) 1.19
Radiation responses of cancer stem cells. J Cell Biochem (2009) 1.08
Anthracyclines, proteasome activity and multi-drug-resistance. BMC Cancer (2005) 1.08
The role of the ubiquitin/proteasome system in cellular responses to radiation. Oncogene (2003) 1.03
Metabolic differences in breast cancer stem cells and differentiated progeny. Breast Cancer Res Treat (2014) 0.98
The RNA-binding protein Musashi-1 regulates proteasome subunit expression in breast cancer- and glioma-initiating cells. Stem Cells (2014) 0.95
Giant negative thermal expansion in bonded MnCoGe-based compounds with Ni2In-type hexagonal structure. J Am Chem Soc (2015) 0.93
Oxygen levels do not determine radiation survival of breast cancer stem cells. PLoS One (2012) 0.92
Radiation-induced Notch signaling in breast cancer stem cells. Int J Radiat Oncol Biol Phys (2013) 0.91
Targeted elimination of breast cancer cells with low proteasome activity is sufficient for tumor regression. Breast Cancer Res Treat (2013) 0.88
Differential Effects of the Proteasome Inhibitor NPI-0052 against Glioma Cells. Transl Oncol (2010) 0.88
Radiation Therapy Oncology Group translational research program stem cell symposium: incorporating stem cell hypotheses into clinical trials. Int J Radiat Oncol Biol Phys (2009) 0.83
Targeted cancer stem cell therapies start with proper identification of the target. Mol Cancer Res (2010) 0.82
Discovery of a potent, selective, and orally bioavailable pyridinyl-pyrimidine phthalazine aurora kinase inhibitor. J Med Chem (2010) 0.82
Radioresistance of prostate cancer cells with low proteasome activity. Prostate (2011) 0.81
Correlation between evolution of resistive switching and oxygen vacancy configuration in La₀.₅Ca₀.₅MnO₃ based memristive devices. Nanotechnology (2012) 0.80
Discovery of 2,4-bis-arylamino-1,3-pyrimidines as insulin-like growth factor-1 receptor (IGF-1R) inhibitors. Bioorg Med Chem Lett (2011) 0.78
Catch-22: does breast cancer radiotherapy have negative impacts too? Future Oncol (2012) 0.75
Large improvement of coercivity in Sm-(Co,Cu)/Fe films by Cu addition. J Nanosci Nanotechnol (2012) 0.75
Corrigendum: Giant barocaloric effect in hexagonal Ni2In-type Mn-Co-Ge-In compounds around room temperature. Sci Rep (2016) 0.75